TINZAPARIN SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for tinzaparin sodium and what is the scope of patent protection?
Tinzaparin sodium
is the generic ingredient in one branded drug marketed by Leo Pharma As and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for tinzaparin sodium.
Summary for TINZAPARIN SODIUM
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 13 |
Patent Applications: | 6,259 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TINZAPARIN SODIUM at DailyMed |
Recent Clinical Trials for TINZAPARIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Imperial College London | Phase 4 |
Michalis Karamouzis | Phase 3 |
Assistance Publique - Hôpitaux de Paris | Phase 3 |
US Patents and Regulatory Information for TINZAPARIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leo Pharma As | INNOHEP | tinzaparin sodium | INJECTABLE;INJECTION | 020484-001 | Jul 14, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |